Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Reviewer acknowledgement

BMC Endocrine Disorders reviewer acknowledgement 2015

Author: Tim Shipley

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Contributing reviewers

The editors of BMC Endocrine Disorders would like to thank all our reviewers who have contributed to the journal in Volume 15 (2015).
Metadata
Title
BMC Endocrine Disorders reviewer acknowledgement 2015
Author
Tim Shipley
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0091-0

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue

Research article

Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults

Research article

Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer

Research article

Is thyroid status associated with cognitive impairment in elderly patients in China?

Research article

Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients

Research article

Gender-modulated risk of coronary heart disease, diabetes and coronary mortality among Turks for three major risk factors, and residual adiposity risk

Research article

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits